Paris-based Lucis, a preventive-health platform that pairs blood biomarker testing with an AI-driven companion app, has raised a $20m Series A led by Singular, with participation from General Catalyst, Y Combinator and angel investors including Céline Lazorthes of Resilience, Manu Lecomte, and backers of the running-coach app Runna. The round arrives four months after the company’s $8.5m seed in […]

This story continues at The Next Web